Financials Oxford Cannabinoid Technologies Holdings Plc
Equities
OCTP
GB00BMVMRB86
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.155 GBX | +3.33% | 0.00% | -75.20% |
May. 08 | Oxford Cannabinoid shares plummet following delisting request | AN |
May. 08 | Oxford Cannabinoid Technologies Files for Delisting From London Bourse | MT |
Valuation
Fiscal Period: April | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|
Capitalization 1 | 11.28 | 13.73 | 1.687 | - |
Enterprise Value (EV) 1 | 11.28 | 11.44 | 0.502 | 3.715 |
P/E ratio | -2.39 x | - | -0.7 x | -0.53 x |
Yield | - | - | - | - |
Capitalization / Revenue | - | - | - | - |
EV / Revenue | - | - | - | - |
EV / EBITDA | - | -1.65 x | -0.15 x | -0.93 x |
EV / FCF | - | - | - | - |
FCF Yield | - | - | - | - |
Price to Book | - | - | - | - |
Nbr of stocks (in thousands) | 960,416 | 960,416 | 1,088,416 | - |
Reference price 2 | 0.0118 | 0.0143 | 0.001550 | 0.001550 |
Announcement Date | 7/25/22 | 8/31/23 | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: April | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|
Net sales 1 | - | - | - | - |
EBITDA 1 | - | -6.935 | -3.438 | -3.984 |
EBIT 1 | - | -7.038 | -3.484 | -3.984 |
Operating Margin | - | - | - | - |
Earnings before Tax (EBT) 1 | - | -7.034 | -3.475 | -3.978 |
Net income 1 | -4.712 | -5.945 | -2.2 | -3.153 |
Net margin | - | - | - | - |
EPS 2 | -0.004910 | - | -0.002200 | -0.002900 |
Free Cash Flow | - | - | - | - |
FCF margin | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - |
Dividend per Share 2 | - | - | - | - |
Announcement Date | 7/25/22 | 8/31/23 | - | - |
Balance Sheet Analysis
Fiscal Period: April | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|
Net Debt 1 | - | - | - | 2.03 |
Net Cash position 1 | - | 2.3 | 1.19 | - |
Leverage (Debt/EBITDA) | - | - | - | -0.509 x |
Free Cash Flow | - | - | - | - |
ROE (net income / shareholders' equity) | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - |
Assets 1 | - | - | - | - |
Book Value Per Share | - | - | - | - |
Cash Flow per Share | - | - | - | - |
Capex | - | - | - | - |
Capex / Sales | - | - | - | - |
Announcement Date | 7/25/22 | 8/31/23 | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-75.20% | 2.05M | |
+29.77% | 49.18B | |
+1.00% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.68% | 26.09B | |
-22.99% | 18.71B | |
+8.22% | 13.26B | |
+32.41% | 12.32B | |
-1.62% | 11.99B |
- Stock Market
- Equities
- OCTP Stock
- Financials Oxford Cannabinoid Technologies Holdings Plc